DESCOVY® for HIV-1 pre-exposure prophylaxis (PrEP) is indicated in at-risk adults and adolescents (≥35 kg) to reduce the risk of sexually acquired HIV-1 infection, excluding individuals at risk from receptive vaginal sex. HIV-1–negative status must be confirmed immediately prior to initiation.
Limitation of Use: DESCOVY FOR PrEP® is not indicated in individuals at risk of HIV-1 from receptive vaginal sex because effectiveness in this population has not been evaluated.
Helpful resources
Resources and tools for healthcare professionals
Below, you can find a variety of digital and downloadable resources designed with information about DESCOVY FOR PrEP® for you and your patients.
Healthcare Professional Resources
DESCOVY FOR PrEP® Leave-Behind
An overview of the pharmacology of TAF, the efficacy and safety results from the DISCOVER Trial, and access information for DESCOVY.
Advancing Access® Brochure
A brochure detailing financial and insurance coverage support resources for eligible patients.
DESCOVY DayTracker™ Pharmacy Fact Sheet
Pharmacy fact sheet designed for professionals with more information about the DayTracker features.
Billing Guide (ICD-10 Code Reference)
Convenient guide with HIV and other STI prevention and diagnostic services codes included to help professionals and patients with insurance claims for reimbursement for applicable services.
PrEP Provider Directory
Directory for patients who require assistance finding an HCP in their area who can prescribe PrEP medication.
Patient Resources
Quick Links
Co-pay and Coverage Support
Gilead Advancing Access® co-pay and coverage support resources for your appropriate patients.
Order HIV Prevention Materials for Your Office
Order HIV prevention and PrEP materials online to be shipped directly to your office.
PrEP Provider Directory
Directory for patients who require assistance finding an HCP in their area who can prescribe PrEP medication.
HIV Treatment Option
Learn more about an HIV treatment option available for your appropriate patients.
HCP=healthcare professional; STI=sexually transmitted infection; TAF=tenofovir alafenamide.